MarketCap
Facebook
X
Telegram
Ardelyx ROA Ratio | ARDX
Annual ROA Ratio Ardelyx
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.36 | -8.95 | -22.18 | -35.25 | -105.5 | -46.79 | -36.55 | -49.8 | -40.75 | -52.73 | -25.33 | -2.83 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.83 | -105.5 | -36.59 |
Quarterly ROA Ratio Ardelyx
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.64 | -21.77 | -14.54 | -19.13 | -22.79 | -12.76 | -10.46 | -18.35 | -25.9 | -18.15 | -33.98 | -57.96 | -75.36 | -63.03 | -85.07 | -69.25 | -85.02 | -63.32 | -77.65 | -61.12 | -51.46 | -46.79 | -40.08 | -40.16 | -37.58 | -36.55 | -44.13 | -48.22 | -50.58 | -49.8 | -28.2 | -28.16 | -32.29 | -40.75 | -61.83 | -62.32 | -59.46 | -52.73 | -52.59 | -54.47 | -33.34 | -25.33 | -14.29 | 1.27 | -3.12 | -2.83 | -9.28 | -11.53 | -16.91 | -9.95 | -2.18 | -2.08 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 | -85.07 | -36.5 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
117.96 | - | -6.63 % | $ 13.9 M |  USA |
 |
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Synthetic Biologics
SYN
|
-62.08 | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.77 | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
-56.09 | - | - | $ 866 M |  China |
 |
Corner Growth Acquisition Corp.
COOL
|
-16.34 | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
-4.6 | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
-34.54 | - | 1.35 % | $ 17.8 M | China |
 |
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-142.36 | - | -13.47 % | $ 169 M | France |
 |
CureVac N.V.
CVAC
|
20.2 | - | - | $ 867 M |  Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B |  Britain |
 |
Завод ДИОД
DIOD
|
2.66 | - | - | - |  Russia |
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | Britain |
 |
Hepion Pharmaceuticals
HEPA
|
-269.64 | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
-21.58 | - | 1052.0 % | $ 415 M | USA |
 |
MorphoSys AG
MOR
|
-9.36 | - | 2.43 % | $ 254 M | Germany |
 |
Codexis
CDXS
|
-29.75 | $ 1.46 | 2.82 % | $ 127 M | USA |
 |
Affimed N.V.
AFMD
|
-109.04 | - | -34.95 % | $ 21.5 M | Germany |
 |
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 23.9 | 1.01 % | $ 3.04 B | USA |
 |
Assembly Biosciences
ASMB
|
-2.38 | $ 36.6 | 1.3 % | $ 410 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-251.78 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
-207.62 | - | - | $ 12.5 M |  Belgium |
 |
Adial Pharmaceuticals
ADIL
|
-119.54 | $ 7.12 | 6.91 % | $ 4.76 M | USA |
 |
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
36.63 | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
-36.68 | - | - | $ 3.37 B | China |
 |
Axsome Therapeutics
AXSM
|
-26.55 | $ 206.68 | 0.16 % | $ 10.3 B | USA |
 |
GlycoMimetics
GLYC
|
0.06 | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
-3.63 | $ 56.8 | 0.94 % | $ 1.63 B | USA |
 |
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | Canada |
 |
AVROBIO
AVRO
|
-28406.21 | - | 1083.1 % | $ 745 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
4.59 | $ 66.53 | 0.15 % | $ 12.8 B | USA |
 |
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | Canada |
 |
Bicycle Therapeutics plc
BCYC
|
-30.51 | $ 4.3 | 1.42 % | $ 298 M | Britain |
 |
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | USA |
 |
ChromaDex Corporation
CDXC
|
16.34 | - | -0.88 % | $ 598 M | USA |